SCHEMBL8768423

SCHEMBL8768423

CCN(CC)C(=O)c1ccc(S(=O)(=O)NC(=O)c2cnc(OC(=O)NCC(=O)O)c(O)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
EGFR P00533 5/20 0.39
NAMPT P43490 1/20 0.38
LIMK1 P53667 1/20 0.38
LIMK2 P53671 1/20 0.38
PTGS2 P35354 5/20 0.38
P4HTM Q9NXG6 3/20 0.38
PTGS1 P23219 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8106135 0.91 LMNA (0.40) LMNAHPGDHTTSMN1; SMN2L3MBTL1
SCHEMBL8767162 0.90 LMNA (0.40) LMNAHPGDHTTSMN1; SMN2L3MBTL1
SCHEMBL8767144 0.87 LMNA (0.38) LMNAHPGDHTTSMN1; SMN2L3MBTL1
SCHEMBL8918674 0.85 EGLN1 (0.46) LMNAHPGDHTTSMN1; SMN2
SCHEMBL8768258 0.83 CA1 (0.39) EGFRLIMK1LIMK2PTGS2P4HTM
SCHEMBL8097664 0.82 ABL1 (0.37) LMNAHPGDHTTSMN1; SMN2EGFR
SCHEMBL9235404 0.80 MAPT (0.46) HTTSMN1; SMN2EGFRPTGS2PTGS1
SCHEMBL8096944 0.80 SMN1; SMN2 (0.39) LMNAHPGDHTTSMN1; SMN2L3MBTL1
SCHEMBL8916746 0.79 EGLN1 (0.42) LMNAHPGDHTTSMN1; SMN2L3MBTL1
SCHEMBL8099449 0.78 LMNA (0.37) LMNAHPGDHTTSMN1; SMN2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0673931-B1 Sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AG (DE) 1997-08-13 EP disclosed
EP-0673931-A1 Sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-27 EP disclosed